granted
on 29 Oct 2024
Last Applicant/ Owned by
86 Morris Avenue
Summit
NJ
07901
Serial Number
90860796 filed on 02th Aug 2021
Registration Number
N/A
Correspondent Address
Xiomara Triana
Xiomara Triana BRISTOL-MYERS SQUIBB COMPANY
TRADEMARKS DEPT., MAILSTOP D4243
PRINCETON, NJ 08648-4000
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprol Read More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical and biological preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders, and monoclonal antibodies for medical use
N/A
N/A
No 90860796
No Service/Collective Mark
No 00160173-US
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
29th Oct 2024 | SOU EXTENSION 4 GRANTED |
29th Oct 2024 | SOU EXTENSION 4 FILED |
29th Oct 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
29th Oct 2024 | SOU TEAS EXTENSION RECEIVED |
06th Apr 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
05th Apr 2024 | SOU TEAS EXTENSION RECEIVED |
05th Apr 2024 | SOU EXTENSION 3 GRANTED |
05th Apr 2024 | SOU EXTENSION 3 FILED |
14th Oct 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
12th Oct 2023 | SOU EXTENSION 2 GRANTED |